ir.geron.com
Geron: Investor Relations: OverviewGeron is a biopharmaceutical company developing first-in-class cancer therapeutics.
http://ir.geron.com/
Geron is a biopharmaceutical company developing first-in-class cancer therapeutics.
http://ir.geron.com/
TODAY'S RATING
>1,000,000
Date Range
HIGHEST TRAFFIC ON
Thursday
LOAD TIME
PAGES IN
THIS WEBSITE
0
SSL
EXTERNAL LINKS
2
SITE IP
23.204.108.48
LOAD TIME
0 sec
SCORE
6.2
Geron: Investor Relations: Overview | ir.geron.com Reviews
https://ir.geron.com
Geron is a biopharmaceutical company developing first-in-class cancer therapeutics.
Genmab A/S - Investors
Genmab A/S - Investors. This website uses cookies to collect statistical information on the use of our website with the goal of improving user experience. Read our cookie policy for more information. Click here to accept the use of cookies on our website. Price and reference information. Read Genmab's latest Company Announcements and Media Releases. Including Genmab's share price, analyst coverage, major shareholders and warrant program. Access Genmab's financial reports, webcasts, presentations and more.
Investors Overview | GenMark Diagnostics, Inc.
Skip to main navigation. You are about to enter another country or region-specific website. Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on products or uses of those products that are not approved in other countries or regions. Do you wish to continue and exit this website? We have detected that you may be viewing the site from the United States. August 17, 2017.
Inter Resources – Online timesheet management system : Login
Welcome to our client portal. Please log in using your username and password provided by our client service team. Please note: passwords are case specific. For support relating to logins, please contact our client service team. Phone: 1300 654 484. Phone: 0203 598 5352. Emember me next time. Sign in with microsoft.
Gentex Corporation - Investor Relations
Skip to main navigation. Stock Quote and Chart. Annual Reports and Proxy Statements. Gentex develops high-value safety and technology products that make the world a safer, simpler, and smarter place. Gentex is committed to continuing to deliver shareholder value by developing advanced electronic products and features for the automotive, aerospace and fire protection industries. Site visitors are encouraged to subscribe to Gentex's Email Alert Service. Mar 9, 2018. Feb 27, 2018. Steve Downing elected Pres...
Aktie
Seit dem 11.11.2015 notiert die Aktie der German Startups Group Berlin GmbH and Co. KGaA im Entry Standard (Open Market) der Frankfurter Wertpapierbörse. Hier finden Sie die aktuellen Stammdaten. Der German Startups Group sowie die Rabattcodes. Anzahl und Art der Aktien. 11984400 auf den Namen lautende Stammaktien ohne Nennbetrag (Stückaktien). Frankfurter Wertpapierbörse / Entry Standard (Open Market). Entry All Share / Tech. Hauck and Aufhäuser Privatbankiers KGaA. HSBC Trinkaus and Burkhardt AG. 17102...
Geron: Investor Relations: Overview
Initial Phase 2 MF Study. Investing in first-in-class cancer therapeutics. ASH 2014 Investor and Analyst Event. Asterias Stock Tax Guidance. Geron is a clinical stage biopharmaceutical company developing a first-in-class telomerase inhibitor, imetelstat, in hematologic myeloid malignancies. Geron Corporation Reports Second Quarter 2015 Financial Results. Geron Corporation Reports First Quarter 2015 Financial Results and Recent Events. 160; 0.08. Data as of 08/07/15 4:00 pm ET. Minimum 20 minute delay.
Gerry Weber IR - IR Startseite
Sie befinden sich hier: Gerry Weber International AG. Neuausrichtung von GERRY WEBER prägt Ergebnis in den ersten neun Monaten 2015/16. GERRY WEBER schließt 1. Halbjahr 2015/16 nach Plan ab und macht erste Fortschritte bei der Neuausrichtung. Q3 Mitteilung / Q3 Finanzbericht 2015/2016.
Getac | Investor Relations | Basic Information
Rugged Mobile Computing Solutions. Rugged Computers, Mechanical Components. Rugged Computers, Mechanical Components. 5F Floor, Building A, No.209, Nangang Rd, Section 1, Taipei, Taiwan. China Trust Commercial Bank.
Cosi - Investor Info - Corporate Overview
Q2 2015 Così, Inc. Earnings Conference Call. 160;at 5:00 pm ET. The Story of Così. From our hand-tossed Signature Salad to our Tomato, Basil, and Mozzarella Sandwich served on delicious warm flatbread, to the comfortable, urbane and contemporary atmosphere - Così is simply good taste. A place where all elements combine to stimulate the senses and create a lasting impression"Fabulous! Minimum 20 minute delay. Cosi, Inc. Reports 2015 Second Quarter Results. There are currently no events scheduled. Q3 2013 ...
gevo | Investor Relations | Investor Overview
Our Science and Technology. Partnerships, Collaborations and Customer Pipeline. Gevo, ethanol and the future of biofuels. Gevo in the News. Q2 2015 Gevo, Inc. Earnings Conference Call. 160;at 4:30 pm ET. Q2 2015 Gevo, Inc. Earnings Conference Call. Tuesday, August 4, 2015 . 4:30 pm ET . Click here for webcast. Click here to add this event to your calendar. Gevo, Inc. at the Jefferies 2015 Industrials Conference. 160;at 11:20 am ET. Gevo, Inc. at the Jefferies 2015 Industrials Conference. 160; 0.11.
SOCIAL ENGAGEMENT